tartaric acid has been researched along with Brittle Bone Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maruo, S; Matsuoka, A; Nakanishi, M; Rai, SK; Uchida, K; Yoh, K | 1 |
| Arribas, I; Fernando Villa, L; Iritia, M; Revilla, M; Rico, H | 1 |
2 other study(ies) available for tartaric acid and Brittle Bone Disease
| Article | Year |
|---|---|
Clinical usefulness of serum tartrate-resistant fluoride-sensitive acid phosphatase activity in evaluating bone turnover.
Topics: Acid Phosphatase; Adult; Aged; Arthritis, Rheumatoid; Biomarkers; Bone and Bones; Bone Remodeling; Case-Control Studies; Colitis, Ulcerative; Female; Fluorides; Humans; Male; Middle Aged; Osteogenesis Imperfecta; Osteoporosis; Predictive Value of Tests; Reference Values; Renal Dialysis; Tartrates; Ultrasonography | 1999 |
Total body bone mineral and tartrate-resistant acid phosphatase levels in type I and III osteogenesis imperfecta.
Topics: Absorptiometry, Photon; Acid Phosphatase; Adolescent; Bone Density; Child; Child, Preschool; Female; Humans; Male; Osteogenesis Imperfecta; Tartrates | 1991 |